Beta-adrenoblockers in clinical practice: is there any difference?
Modern views on various β-adrenoblockers (BB) place in clinical practice are presented. BB class is a clinically heterogeneous group. Recent criticism of BB should not disorient practitioners, who must understand which BB are mentioned. Some BB, mostly non-selective, demonstrate adverse effects and...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Modern views on various β-adrenoblockers (BB) place in clinical practice are presented. BB class is a clinically heterogeneous group. Recent criticism of BB should not disorient practitioners, who must understand which BB are mentioned. Some BB, mostly non-selective, demonstrate adverse effects and cannot be used in certain clinical situations: metabolic disturbances, chronic obstructive pulmonary disease (COPD), peripheral artery atherosclerosis. At the same time, modern super-selective BB are safe and can be administered even in individuals with metabolic syndrome, diabetes mellitus, COPD, or peripheral artery atherosclerosis. |
|---|---|
| ISSN: | 1728-8800 2619-0125 |